Mr Richard H Bechtol, MD | |
3501 Soncy Road, Suite 126, Amarillo, TX 79119 | |
(806) 353-4328 | |
(806) 355-1347 |
Full Name | Mr Richard H Bechtol |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 3501 Soncy Road, Amarillo, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780620757 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | F5151 (Texas) | Primary |
Entity Name | Kathleen A Clark |
---|---|
Entity Type | Practitioner - Internal Medicine |
Entity Identifiers | NPI Number: 1518103886 PECOS PAC ID: 5294890414 Enrollment ID: I20090223000077 |
News Archive
A new 'seek-and-destroy' gene therapeutic system could have the potential to treat prostate cancer in the future, after it halted the majority of tumors in laboratory models at the University of Strathclyde and the Beatson Institute.
With a $416,000 grant from the National Institutes of Health (NIH), SLU scientists will continue work to cure hepatitis B, building on significant findings published in two recent papers.
Astellas today announced that the U.S. Food and Drug Administration has approved its New Drug Application (NDA) for the use of CRESEMBA (isavuconazonium sulfate), the prodrug for isavuconazole, for patients 18 years of age and older in the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis).
New research offers a possible strategy for treating central nervous system diseases, such as brain and spinal cord injury, brain cancer, epilepsy, and neurological complications of HIV. The experimental treatment method allows small therapeutic agents to safely cross the blood-brain barrier in laboratory rats by turning off P-glycoprotein, one of the main gatekeepers preventing medicinal drugs from reaching their intended targets in the brain.
Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug discovery - linking together generative chemistry and biology for the first time - to discover a novel preclinical candidate addressing idiopathic pulmonary fibrosis ("IPF") and be validated with multiple human cell and animal model experiments.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Richard H Bechtol, MD 3501 Soncy Road, Suite 126, Amarillo, TX 79119 Ph: (806) 353-4328 | Mr Richard H Bechtol, MD 3501 Soncy Road, Suite 126, Amarillo, TX 79119 Ph: (806) 353-4328 |
News Archive
A new 'seek-and-destroy' gene therapeutic system could have the potential to treat prostate cancer in the future, after it halted the majority of tumors in laboratory models at the University of Strathclyde and the Beatson Institute.
With a $416,000 grant from the National Institutes of Health (NIH), SLU scientists will continue work to cure hepatitis B, building on significant findings published in two recent papers.
Astellas today announced that the U.S. Food and Drug Administration has approved its New Drug Application (NDA) for the use of CRESEMBA (isavuconazonium sulfate), the prodrug for isavuconazole, for patients 18 years of age and older in the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis).
New research offers a possible strategy for treating central nervous system diseases, such as brain and spinal cord injury, brain cancer, epilepsy, and neurological complications of HIV. The experimental treatment method allows small therapeutic agents to safely cross the blood-brain barrier in laboratory rats by turning off P-glycoprotein, one of the main gatekeepers preventing medicinal drugs from reaching their intended targets in the brain.
Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug discovery - linking together generative chemistry and biology for the first time - to discover a novel preclinical candidate addressing idiopathic pulmonary fibrosis ("IPF") and be validated with multiple human cell and animal model experiments.
› Verified 1 days ago
Elizabeth Tu, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 S Coulter St Ste 5100, Amarillo, TX 79106 Phone: 806-414-9559 Fax: 806-351-3767 | |
Dr. David Thetford, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 275 Casino Dr, Amarillo, TX 79118 Phone: 806-884-9943 | |
Brian Gillette, MHS, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1100 S Coulter St, Amarillo, TX 79106 Phone: 806-468-9700 | |
Pamela K Banister, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3501 S Soncy Rd Ste 150, Amarillo, TX 79119 Phone: 806-212-6353 Fax: 806-212-0558 | |
Dr. Wesley Scott Nickens, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2701 S Georgia St, Amarillo, TX 79109 Phone: 806-350-8980 Fax: 806-350-7573 | |
Genkai Jason Huang, Family Medicine Medicare: Medicare Enrolled Practice Location: 2701 S Georgia St, Amarillo, TX 79109 Phone: 806-350-8980 Fax: 806-350-7573 | |
Gary J Hilton, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2701 S Georgia St, Amarillo, TX 79109 Phone: 806-350-3000 Fax: 806-350-3337 |